Ameritas Advisory Services’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Ameritas Advisory Services's TXG Position: Q3 2026 in Review
Ameritas Advisory Services reduced its 10x Genomics (TXG) stake by 54% in Q3 2026, selling an estimated $9.36K and leaving 137 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.
Ameritas Advisory Services first reported a position in TXG in Q4 2021 and has held it in 11 quarters since. The position peaked at $3.79M in Q4 2021. 491 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Ameritas Advisory Services held 137 shares of 10x Genomics worth $12.4K as of Q3 2026.
- Ameritas Advisory Services sold 160 10x Genomics shares in Q3 2026, an estimated $9.36K.
- 10x Genomics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #1469 holding.
- Ameritas Advisory Services first reported a position in 10x Genomics in Q4 2021 and has held it in 11 quarters since.
- Ameritas Advisory Services's 10x Genomics position peaked at $3.79M in Q4 2021.
- 491 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.